Myocardial contrast echocardiography without significant hemodynamic effects or reactive hyperemia

A major advantage in the imaging of regional myocardial perfusion

Mark W. Keller, William Glasheen, Kuldeep Teja, Adrian Gear, Sanjiv Kaul

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

All agents used for myocardial contrast echocardiography to date produce adverse hemodynamic effects and alter coronary blood flow. It was hypothesized that because 5% human albumin, when sonicated for use as a contrast agent, is neither hyperosmolar nor a calcium chelator, it would not have significant effects on coronary blood flow, left ventricular function or systemic hemodynamics. Albumin microbubbles of two distinct sizes (mean size 2.9 and 5.8 μm) were produced and compared with nonsonicated albumin, nonsonicated Renografin, sonicated Renografin and hand-agitated Renografin for their effects on hemodynamics, coronary mood flow and regional left ventricular systolic thickening in 15 open chest anesthetized dogs. None of the albumin solutions significantly altered left atrial, left ventricular systolic and end-diastolic and mean aortic pressures. These agents did not cause a coronary hyperemic response or alter left ventricular systolic thickening, but slightly lowered the peak positive left ventricular maximal rate of rise in pressure ( dP dt) (-4.1 ± 5.4%, p <0.01). In contrast, all the Renografin solutions caused significant changes in all these variables (p <0.02). In six dogs, albumin solutions did not alter these variables even in the presence of critical coronary stenosis. The contrast opacification produced by 5.8 μm albumin microbubbles was equivalent to that produced by sonicated Renografin. Compared with an equivalent amount of saline and nonsonicated albumin solutions, 10 ml of sonicated albumin did not produce any evidence of infarction, embolization or hemorrhage in the myocardium, brain or kidneys of rabbits. In conclusion, intracoronary injection of sonicated albumin does not alter coronary blood flow, left ventricular function or systemic hemodynamics, offering a major advantage in the imaging of regional myocardial perfusion.

Original languageEnglish (US)
Pages (from-to)1039-1047
Number of pages9
JournalJournal of the American College of Cardiology
Volume12
Issue number4
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Myocardial Perfusion Imaging
Hyperemia
Echocardiography
Albumins
Diatrizoate Meglumine
Hemodynamics
Microbubbles
Left Ventricular Function
Dogs
Coronary Stenosis
Infarction
Contrast Media
Myocardium
Arterial Pressure
Thorax
Hand
Hemorrhage
Rabbits
Kidney
Pressure

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Myocardial contrast echocardiography without significant hemodynamic effects or reactive hyperemia : A major advantage in the imaging of regional myocardial perfusion. / Keller, Mark W.; Glasheen, William; Teja, Kuldeep; Gear, Adrian; Kaul, Sanjiv.

In: Journal of the American College of Cardiology, Vol. 12, No. 4, 1988, p. 1039-1047.

Research output: Contribution to journalArticle

@article{a8993817fe6a4cf089339ff9ca83b831,
title = "Myocardial contrast echocardiography without significant hemodynamic effects or reactive hyperemia: A major advantage in the imaging of regional myocardial perfusion",
abstract = "All agents used for myocardial contrast echocardiography to date produce adverse hemodynamic effects and alter coronary blood flow. It was hypothesized that because 5{\%} human albumin, when sonicated for use as a contrast agent, is neither hyperosmolar nor a calcium chelator, it would not have significant effects on coronary blood flow, left ventricular function or systemic hemodynamics. Albumin microbubbles of two distinct sizes (mean size 2.9 and 5.8 μm) were produced and compared with nonsonicated albumin, nonsonicated Renografin, sonicated Renografin and hand-agitated Renografin for their effects on hemodynamics, coronary mood flow and regional left ventricular systolic thickening in 15 open chest anesthetized dogs. None of the albumin solutions significantly altered left atrial, left ventricular systolic and end-diastolic and mean aortic pressures. These agents did not cause a coronary hyperemic response or alter left ventricular systolic thickening, but slightly lowered the peak positive left ventricular maximal rate of rise in pressure ( dP dt) (-4.1 ± 5.4{\%}, p <0.01). In contrast, all the Renografin solutions caused significant changes in all these variables (p <0.02). In six dogs, albumin solutions did not alter these variables even in the presence of critical coronary stenosis. The contrast opacification produced by 5.8 μm albumin microbubbles was equivalent to that produced by sonicated Renografin. Compared with an equivalent amount of saline and nonsonicated albumin solutions, 10 ml of sonicated albumin did not produce any evidence of infarction, embolization or hemorrhage in the myocardium, brain or kidneys of rabbits. In conclusion, intracoronary injection of sonicated albumin does not alter coronary blood flow, left ventricular function or systemic hemodynamics, offering a major advantage in the imaging of regional myocardial perfusion.",
author = "Keller, {Mark W.} and William Glasheen and Kuldeep Teja and Adrian Gear and Sanjiv Kaul",
year = "1988",
doi = "10.1016/0735-1097(88)90474-3",
language = "English (US)",
volume = "12",
pages = "1039--1047",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Myocardial contrast echocardiography without significant hemodynamic effects or reactive hyperemia

T2 - A major advantage in the imaging of regional myocardial perfusion

AU - Keller, Mark W.

AU - Glasheen, William

AU - Teja, Kuldeep

AU - Gear, Adrian

AU - Kaul, Sanjiv

PY - 1988

Y1 - 1988

N2 - All agents used for myocardial contrast echocardiography to date produce adverse hemodynamic effects and alter coronary blood flow. It was hypothesized that because 5% human albumin, when sonicated for use as a contrast agent, is neither hyperosmolar nor a calcium chelator, it would not have significant effects on coronary blood flow, left ventricular function or systemic hemodynamics. Albumin microbubbles of two distinct sizes (mean size 2.9 and 5.8 μm) were produced and compared with nonsonicated albumin, nonsonicated Renografin, sonicated Renografin and hand-agitated Renografin for their effects on hemodynamics, coronary mood flow and regional left ventricular systolic thickening in 15 open chest anesthetized dogs. None of the albumin solutions significantly altered left atrial, left ventricular systolic and end-diastolic and mean aortic pressures. These agents did not cause a coronary hyperemic response or alter left ventricular systolic thickening, but slightly lowered the peak positive left ventricular maximal rate of rise in pressure ( dP dt) (-4.1 ± 5.4%, p <0.01). In contrast, all the Renografin solutions caused significant changes in all these variables (p <0.02). In six dogs, albumin solutions did not alter these variables even in the presence of critical coronary stenosis. The contrast opacification produced by 5.8 μm albumin microbubbles was equivalent to that produced by sonicated Renografin. Compared with an equivalent amount of saline and nonsonicated albumin solutions, 10 ml of sonicated albumin did not produce any evidence of infarction, embolization or hemorrhage in the myocardium, brain or kidneys of rabbits. In conclusion, intracoronary injection of sonicated albumin does not alter coronary blood flow, left ventricular function or systemic hemodynamics, offering a major advantage in the imaging of regional myocardial perfusion.

AB - All agents used for myocardial contrast echocardiography to date produce adverse hemodynamic effects and alter coronary blood flow. It was hypothesized that because 5% human albumin, when sonicated for use as a contrast agent, is neither hyperosmolar nor a calcium chelator, it would not have significant effects on coronary blood flow, left ventricular function or systemic hemodynamics. Albumin microbubbles of two distinct sizes (mean size 2.9 and 5.8 μm) were produced and compared with nonsonicated albumin, nonsonicated Renografin, sonicated Renografin and hand-agitated Renografin for their effects on hemodynamics, coronary mood flow and regional left ventricular systolic thickening in 15 open chest anesthetized dogs. None of the albumin solutions significantly altered left atrial, left ventricular systolic and end-diastolic and mean aortic pressures. These agents did not cause a coronary hyperemic response or alter left ventricular systolic thickening, but slightly lowered the peak positive left ventricular maximal rate of rise in pressure ( dP dt) (-4.1 ± 5.4%, p <0.01). In contrast, all the Renografin solutions caused significant changes in all these variables (p <0.02). In six dogs, albumin solutions did not alter these variables even in the presence of critical coronary stenosis. The contrast opacification produced by 5.8 μm albumin microbubbles was equivalent to that produced by sonicated Renografin. Compared with an equivalent amount of saline and nonsonicated albumin solutions, 10 ml of sonicated albumin did not produce any evidence of infarction, embolization or hemorrhage in the myocardium, brain or kidneys of rabbits. In conclusion, intracoronary injection of sonicated albumin does not alter coronary blood flow, left ventricular function or systemic hemodynamics, offering a major advantage in the imaging of regional myocardial perfusion.

UR - http://www.scopus.com/inward/record.url?scp=0023801551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023801551&partnerID=8YFLogxK

U2 - 10.1016/0735-1097(88)90474-3

DO - 10.1016/0735-1097(88)90474-3

M3 - Article

VL - 12

SP - 1039

EP - 1047

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 4

ER -